Long Term Results after 3 Courses of ABVD Plus Subtotal Nodal Radiotherapy in 188 Adult Patients with Stage Ι,ΙΙ and ΙΙΙA Hodgin Lymphoma
Pauline Brice, Marc André², Patricia Franchi-Rezgui, Irène Biasoli, C.Hennequin
Hôpital Saint Louis AP-HP, services d’hématologie et radiothérapie, Paris, France. ²Hôpital Notre Dame, Charleroi, Belgique.
Abstract
In patients with Hodgkin lymphoma (HL) a continued improvement in outcome with a high cure rate is observed but with an increased treatment-induced late effects. We report the long-term results from 188 (stage I to IIIA) patients treated during the period 1985–94 with 3 courses of ABVD-like chemotherapy and subtotal nodal radiotherapy. 10 year overall survival is of 88% and no secondary leukaemia was observed. The main long term toxicity was cardiac, mainly related to a mediastinal dose of 45 Grays in patients with partial remission. New strategies are aiming to reduce the mediastinal dose at 30 Grays after chemotherapy-induced complete remission.
Readers of this also read:
- Occurrence of Acute Myeloid Leukemia in Young Pregnant Women
- Mammoth and Elephant Phylogenetic Relationships: Mammut Americanum, the Missing Outgroup
- Systems Biology-Based Identification of Crosstalk between E2F Transcription Factors and the Fanconi Anemia Pathway
- Quantification of Drug-Induced mRNA in Human Whole Blood ex vivo
- Quantification of Drug-Induced mRNA in Human Whole Blood ex vivo
